Reh In Vivo Tumorigenesis Assay

CAT#: ITS-1122-YF4933
Target Cell Organism: Human
Target Cell Name: Reh
Assay Type: Oncology In Vivo Assays
Assay Overview
This assay is to provide Reh-based In Vivo Tumorigenesis Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Reh
Target Cell Organism
Human
Target Cell Background
Reh is a human cell line exhibiting lymphoblastic morphology that was isolated from tissue from an acute lymphocytic leukemia (ALL) patient. Use these cells in your immune system disorder and cancer research.
Related Diseases
Acute Lymphocytic Leukemia; ALL
Research Area
Oncology
Assay Name
In Vivo Tumorigenesis Assay
Short Description
Reh-cell based In Vivo Tumorigenesis Assay
Assay Description
Tumorigenicity is defined the property of a cell to form tumors when inoculated into an immunosuppressed animal model. Generally, test cells and tumor cells as positive control are administered subcutaneously into immunosuppressed nude mice. The number of animals developing tumors are compared with a positive control reference cell line.
Assay Type
Oncology In Vivo Assays
For Research Use Only | Not For Clinical Use
Online Inquiry